Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials

Michael Singer,1 Mimi Liu,2 Patricio G Schlottmann,3 Arshad M Khanani,4 Miranda Hemphill,5 Lauren Hill,5 Lisa Tuomi,5 Zdenka Haskova5 1Medical Center Ophthalmology Associates, San Antonio, TX, USA; 2Colorado Retina Associates, Denver, CO, USA; 3Organizacion Medica de Investigacion, Buenos Aires, Arg...

Full description

Bibliographic Details
Main Authors: Singer M, Liu M, Schlottmann PG, Khanani AM, Hemphill M, Hill L, Tuomi L, Haskova Z
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Clinical Ophthalmology
Subjects:
diabetic retinopathy
ranibizumab
anti-vegf
diabetic macular edema
post hoc
Online Access:https://www.dovepress.com/predictors-of-early-diabetic-retinopathy-regression-with-ranibizumab-i-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/predictors-of-early-diabetic-retinopathy-regression-with-ranibizumab-i-peer-reviewed-article-OPTH

Similar Items